Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemiparkinsonism with hemiatrophy.

A S Buchman1, C G Goetz, H L Klawans

  • 1Department of Neurological Sciences, Rush-Presbyterian-St. Lukes Medical Center, Chicago, IL 60612.

Neurology
|April 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loneliness Predicts Progression of Frailty in Married and Widowed, but Not Unmarried Community Dwelling Older Adults.

The Journal of frailty & aging·2024
Same author

MIND Diet Associated with Reduced Incidence and Delayed Progression of ParkinsonismA in Old Age.

The journal of nutrition, health & aging·2018
Same author

Expanding the Toolkit for Studies of Aging.

The journal of prevention of Alzheimer's disease·2017
Same author

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Movement disorders : official journal of the Movement Disorder Society·2017
Same author

Neuronal-expressed microRNA-targeted pseudogenes compete with coding genes in the human brain.

Translational psychiatry·2017
Same author

Revue neurologique·2017
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Hemiparkinsonism with ipsilateral hemiatrophy (HP/HA) presents with asymmetric parkinsonism, early onset, and dystonia. This condition progresses slower than idiopathic Parkinson's disease (IPD), suggesting a better prognosis.

Area of Science:

  • Neurology
  • Movement Disorders
  • Neurodegenerative Diseases

Background:

  • Hemiparkinsonism with ipsilateral hemiatrophy (HP/HA) is a rare syndrome requiring detailed clinical characterization.
  • Understanding HP/HA's progression is crucial for differentiating it from idiopathic Parkinson's disease (IPD).

Purpose of the Study:

  • To delineate the clinical features of HP/HA.
  • To assess the rate of disease progression in HP/HA patients.
  • To compare HP/HA with IPD.

Main Methods:

  • Retrospective analysis of fifteen HP/HA patients.
  • Comparison with a control population of IPD patients.
  • Evaluation of clinical signs, age of onset, birth history, dystonia, and time to levodopa therapy.

Related Experiment Videos

Main Results:

  • HP/HA patients exhibited highly asymmetric parkinsonism contralateral to hemiatrophy.
  • Early age of onset (43.7 years) and abnormal birth history were noted in HP/HA.
  • Dystonia preceded levodopa therapy in most HP/HA patients.
  • Disease duration to levodopa initiation was significantly longer in HP/HA (14.2 years) vs. IPD (4.1 years).

Conclusions:

  • HP/HA is clinically distinct from IPD, characterized by asymmetry and early onset.
  • The slow progression rate suggests a more favorable prognosis for HP/HA compared to IPD.
  • Further research into the specific mechanisms underlying HP/HA is warranted.